BioSpace News Archive

Milan Patel, co-founder and CEO of PathogenDx, an Arizona-based biotechnology company that has developed a multiplexed microarray molecular-based pathogen testing platform, issued the following letter to U.S. President Joe Biden, urging him to implement next-generation diagnostic technologies in the battle against the COVID-19 pandemic.

Agenus (NASDAQ: AGEN), today announced the publication of results in the Journal of Clinical Oncology (JCO) from a global Phase 2 clinical study of balstilimab (Bal) plus zalifrelimab (Zal) in second-line (2L) recurrent/metastatic cervical cancer patients who had relapsed after treatment with platinum-based therapy.

Predicine Corporation, a global molecular insights company, announced the appointment of Linh H. Le as its new Chief Financial Officer.

CytoDyn Inc. today announced that the U.S. District Court for the District of Maryland has granted CytoDyn’s previously-announced motion for a preliminary injunction against NSF International, Inc. and its subsidiary Amarex Clinical Research (“Amarex”), the Company’s former Contract Research Organization (“CRO”).

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology today announced the FDA has granted De Novo Clearance for Philips IVC Filter Removal Laser Sheath – CavaClear – to remove an IVC filter when previous methods of removal have failed.

X-Therma Inc., a biotechnology company developing breakthrough technology for regenerative medicine and organ preservation - has closed an oversubscribed $13M Series A funding round.

Acadia Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022.

Affinivax, Inc. (“Affinivax”), a clinical stage biopharmaceutical company pioneering the development of a novel class of vaccines with its MAPS™ (Multiple Antigen Presenting System) technology platform, today announced the appointment of Dr. Rick Malley as Chief Scientific Officer.

CEL-SCI Corporation (NYSE American: CVM) reported financial results for the fiscal year ended September 30, 2021, as well as key clinical and corporate developments.

According to Emergen Research, the global 2D chromatography market size was USD 33.9 Million in 2020 and is expected to reach USD 60 Million in 2028 and register a revenue CAGR of 7.3% during the forecast period, 2021-2028.